Here you can learn how to add new statistical methods to your toolbox. These may not be neccessarily cutting edge methods, but approaches, that you are not yet aware about.
If you ask someone within the pharma world of statisticians on what is the hottest topic, you most likely will just get: Estimands! Many scientific events, conference sessions, publications and presentations are organized around this topic. Thus, I’m super happy, that we have Mouna and Chrissie on the podcast as they have presented about this …
We’re all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes …
How to make the right portfolio decisions – Interview with Andreas Sashegyi Read More »
Are you still counting tables? Do you worry about having to many of them? Do you wonder how to get an overview across all the results? In this episode, we will talk about this thoughts and we will explore, how tables fit into the bigger picture. We will also discuss alternative ways to deal with …
Do you think, you have nothing to add to a statistical conference? Are you afraid of sharing your achievements? Do you wonder, why you should put in the effort on top of your day-to-day job? All these thoughts and questions will be addressed in this episode with Paul Terrill, the chair of the scientific committee …
Why and how to present at the next PSI conference – Interview with Paul Terrill Read More »
Alex Dmitrienko has researched and published so much, that without a doubt, he can be called one of the world class experts in the field of multiplicity. E.g. his book Multiple Testing Problems in Pharmaceutical Statistics contains a wealth of practical information on this topic. His career has brought him from pharma over CROs to …
Indirect comparisons provide evidence, when no direct clinical trials are available. However, the different approaches come with various limitations. Some more recent approaches take into account the baseline characteristics to reduce the bias in the estimates of the treatment effects. In todays episode, I’m talking with one the worlds experts on this topic – Nicky …